111, Inc. Sponsored ADR (NASDAQ:YI) Sees Significant Decrease in Short Interest

Key Points

• 111, Inc. Sponsored ADR (NASDAQ:YI) experienced a dramatic 78.6% decline in short interest in August, with short interest totaling just 900 shares as of August 31st.
• The company's most recent quarterly earnings reported a loss of ($0.20) EPS and revenue of $486.35 million, with a current stock price of $5.79.
• Institutional investors hold approximately 21.32% of the stock, with Connor Clark & Lunn Investment Management recently acquiring a new stake valued at about $92,000.

111, Inc. Sponsored ADR (NASDAQ:YI - Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 900 shares, a drop of 78.6% from the August 15th total of 4,200 shares. Currently, 0.0% of the company's shares are sold short. Based on an average daily trading volume, of 12,300 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 12,300 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company's shares are sold short.

111 Stock Performance

Shares of NASDAQ YI traded down $0.38 during mid-day trading on Wednesday, hitting $5.65. 60,846 shares of the stock traded hands, compared to its average volume of 19,938. 111 has a 52 week low of $4.14 and a 52 week high of $11.90. The company has a market cap of $48.82 million, a price-to-earnings ratio of -8.83 and a beta of 0.46. The stock has a fifty day moving average price of $6.77 and a 200-day moving average price of $7.63.

111 (NASDAQ:YI - Get Free Report) last released its quarterly earnings results on Wednesday, September 17th. The company reported ($0.40) earnings per share for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a "sell (d-)" rating on shares of 111 in a research report on Saturday.

Institutional Investors Weigh In On 111

An institutional investor recently bought a new position in 111 stock. Connor Clark & Lunn Investment Management Ltd. bought a new position in 111, Inc. Sponsored ADR (NASDAQ:YI - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 11,338 shares of the company's stock, valued at approximately $92,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.13% of 111 at the end of the most recent quarter. Institutional investors and hedge funds own 21.32% of the company's stock.

111 Company Profile

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.